⌕
Illumina · ILMN · Nasdaq
Tenet 52 · Mixed
Compare
$202.61+2.33%At closeTenet 52 · Mixed
$202.61+4.61 (+2.33%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
$204.00+1.39 (+0.69%)
After hours: Nov 17, 2026, 6:51 PM ET

Illumina (ILMN) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is ILMN's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Seeking AlphaNov 17, 2026 · 09:43 ET
Illumina, Inc. (ILMN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Illumina, Inc. (ILMN) Presents at Jefferies Global Healthcare Conference 2026 Transcript…

ILMN +2.3% todayRead at source ↗
● MarketBeatNov 17, 2026 · 09:13 ET
Illumina Sees Strong Clinical Demand, but Research Recovery Remains in Question

Illumina NASDAQ: ILMN is seeing strong demand for its sequencing instruments from clinical customers, while remaining cautious about a recovery in research spending, Chief Financial Officer Ankur Dhingra said at a compan…

ILMN +2.3% todayRead at source ↗
● Seeking AlphaNov 16, 2026 · 22:40 ETEARNINGS EXPECTED BY FEB 8
Thrivent Mid Cap Stock Fund Q3 2026 Performance Review

Thrivent Mid Cap Stock Fund returned (2.92%) versus the Russell Mid Cap Index's (3.00%) return. Top contributors include Veeva Systems, Illumina and Zebra Tech. Top detractors include RH and UL Solutions.…

ILMN +2.3% todayRead at source ↗
● MarketBeatNov 10, 2026 · 19:15 ET
Illumina Bets on Clinical Demand for Growth as Research Funding Uncertainty Persists

Illumina NASDAQ: ILMN expects clinical demand and sequencing consumables to remain central to its growth strategy, even as research customers continue to face uncertainty over grant funding, executives said at a UBS disc…

ILMN +2.3% todayRead at source ↗
● Seeking AlphaNov 10, 2026 · 15:31 ET
Illumina, Inc. (ILMN) Presents at 2026 UBS Global Healthcare Conference Transcript

Illumina, Inc. (ILMN) Presents at 2026 UBS Global Healthcare Conference Transcript…

ILMN +2.3% todayRead at source ↗
● PRNewsWireNov 9, 2026 · 09:15 ETCOMPANY'S OWN WORDS
Illumina advances MRD research portfolio with ultrasensitive duplex sequencing technology

Early access program launches to support ultrasensitive research into molecular residual disease and tumor evolution. New chemistry is optimized for highest possible accuracy, with reproducible detection of ctDNA at 2.5 …

ILMN +2.3% todayRead at source ↗
● Defense WorldNov 7, 2026 · 05:36 ET
Illumina (NASDAQ:ILMN) Stock: Insider Keith Meister Sells 50,000 Shares

Illumina, Inc. (NASDAQ: ILMN - Get Free Report) Director Keith Meister sold 50,000 shares of the business's stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $227.17, for a…

ILMN +2.3% todayRead at source ↗
● Defense WorldNov 5, 2026 · 04:06 ETEARNINGS EXPECTED BY FEB 8
Illumina, Inc. $ILMN Shares Sold by AIA Group Ltd

AIA Group Ltd trimmed its position in Illumina, Inc. (NASDAQ: ILMN) by 35.9% in a recent quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,895 s…

ILMN +2.3% todayRead at source ↗
● Zacks Investment ResearchNov 4, 2026 · 12:41 ET
REGN vs. ILMN: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Regeneron (REGN) and Illumina (ILMN). But which of these two stocks presents investors with the better value opportunity…

ILMN +2.3% todayRead at source ↗
● PRNewsWireNov 2, 2026 · 20:00 ETCOMPANY'S OWN WORDS
Illumina selected to help bring precision medicine into everyday healthcare in Singapore

SG-INSIGHT study will extend whole-genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore's healthcare system SINGAPORE, Nov. 2, 20…

ILMN +2.3% todayRead at source ↗
● Zacks Investment ResearchNov 2, 2026 · 10:46 ET
Why Illumina (ILMN) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.…

ILMN +2.3% todayRead at source ↗
● Zacks Investment ResearchNov 2, 2026 · 10:16 ET
Don't Overlook Illumina (ILMN) International Revenue Trends While Assessing the Stock

Explore Illumina's (ILMN) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.…

ILMN +2.3% todayRead at source ↗
● Zacks Investment ResearchOct 30, 2026 · 11:11 ET
3 Promising Genomics Stocks to Add to Your Portfolio Now

Genomics and synthetic biology are transforming healthcare through precision medicine and gene editing, putting ILMN, QURE and TXG in focus as the markets expand.…

ILMN +2.3% todayRead at source ↗
● Zacks Investment ResearchOct 30, 2026 · 11:01 ETEARNINGS EXPECTED BY FEB 8
ILMN Q3 Earnings Call Highlights Higher Guidance and Clinical Growth

Illumina raises its 2026 guidance as strong clinical sequencing demand and NovaSeq X adoption fuel growth despite research weakness and pricing pressures.…

ILMN +2.3% todayRead at source ↗
● Zacks Investment ResearchOct 29, 2026 · 21:30 ETEARNINGS EXPECTED BY FEB 8
Illumina (ILMN) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Illumina (ILMN) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and t…

ILMN +2.3% todayRead at source ↗
● Seeking AlphaOct 29, 2026 · 19:28 ETEARNINGS EXPECTED BY FEB 8
Illumina, Inc. (ILMN) Q3 2026 Earnings Call Transcript

Illumina, Inc. (ILMN) Q3 2026 Earnings Call Transcript…

ILMN +2.3% todayRead at source ↗
● Zacks Investment ResearchOct 29, 2026 · 18:36 ETEARNINGS EXPECTED BY FEB 8
Illumina (ILMN) Q3 Earnings Beat Estimates

Illumina (ILMN) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.34 per share a year ago.…

ILMN +2.3% todayRead at source ↗
● MarketBeatOct 29, 2026 · 18:15 ETEARNINGS EXPECTED BY FEB 8
Illumina Q3 Earnings Call Highlights

Illumina NASDAQ: ILMN reported third-quarter results above its prior guidance, citing strong clinical sequencing demand, elevated NovaSeq X instrument placements and disciplined spending. The company raised its full-year…

ILMN +2.3% todayRead at source ↗
● BenzingaOct 29, 2026 · 17:37 ETEARNINGS EXPECTED BY FEB 8
Illumina Q3 2026 Earnings Call Transcript

Illumina (NASDAQ:ILMN) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.…

ILMN +2.3% todayRead at source ↗
● PRNewsWireOct 29, 2026 · 16:05 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 8
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026

SAN DIEGO, Oct. 29, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the third quarter of fiscal year 2026. Third quarter 2026 results Reported re…

ILMN +2.3% todayRead at source ↗
● Seeking AlphaOct 29, 2026 · 03:50 ETEARNINGS EXPECTED BY FEB 8
Diamond Hill Small-Mid Cap Fund Q3 2026 Contributors And Detractors

The Fund declined 4.75% while the Russell 2500 Index declined 6.37%. Key contributors include Illumina, Revvity and Waystar. Key detractors include Regal Rexnord, Knife River and Red Rock Resorts.…

ILMN +2.3% todayRead at source ↗
● Zacks Investment ResearchOct 28, 2026 · 10:16 ETEARNINGS EXPECTED BY FEB 8
Illumina (ILMN) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Evaluate the expected performance of Illumina (ILMN) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insigh…

ILMN +2.3% todayRead at source ↗
● PRNewsWireOct 27, 2026 · 16:15 ETCOMPANY'S OWN WORDS
Illumina To Webcast Upcoming Investor Conference

SAN DIEGO, Oct. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor Conference Jefferies Glo…

ILMN +2.3% todayRead at source ↗
● PRNewsWireOct 21, 2026 · 09:15 ETCOMPANY'S OWN WORDS
Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery

DRAGEN Ultra, BioInsight Platform Workflow Orchestrator, and BioInsight Platform Learning Cohorts are now available in early access, incorporating new AI-driven approaches to analysis, automation, and discovery The tools…

ILMN +2.3% todayRead at source ↗
● PRNewsWireOct 20, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Illumina To Webcast Upcoming Investor Conference

SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor Conference UBS Global He…

ILMN +2.3% todayRead at source ↗
● PRNewsWireOct 14, 2026 · 09:15 ETCOMPANY'S OWN WORDS
Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs

The new platform brings together advanced analysis, purpose-built AI, and curated biological data so researchers can move more quickly from complex genomic and multiomic data to actionable insight Included in the new pla…

ILMN +2.3% todayRead at source ↗
● PRNewsWireOct 8, 2026 · 16:06 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 8
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026

SAN DIEGO, Oct. 8, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2026 following the close of market on Thursday, October 29, 2026. On the same day, at…

ILMN +2.3% todayRead at source ↗
● PRNewsWireOct 8, 2026 · 09:15 ETCOMPANY'S OWN WORDS
Illumina releases SpliceAI2 to help advance rare disease research

In a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared to other splicing models Illumina's genomic AI models now collectively enable researchers to identify 2x as many varian…

ILMN +2.3% todayRead at source ↗
● PRNewsWireSep 4, 2026 · 19:15 ETEARNINGS EXPECTED BY FEB 8
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

NEW YORK, Sept. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, Septem…

ILMN +2.3% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 8. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

NVDA33−0.4%
DLB4−3.8%
WDAY4−5.8%

Article counts from the last market-wide feed page, across every symbol we track and not just ILMN · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.